Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality
- PMID: 20678043
- DOI: 10.5694/j.1326-5377.2010.tb03835.x
Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality
Abstract
Objective: To examine the impact of a national current affairs television program about the association between osteonecrosis of the jaw and bisphosphonates on subsequent prescription use, fractures and deaths.
Design and setting: National Pharmaceutical Benefits Scheme prescription data for 9 months after the television program were used to estimate the impact of reduced bisphosphonate use on fractures and mortality.
Main outcome measures: Prescription rates, fractures and deaths.
Results: The estimated reduction of 29 633 in the number of bisphosphonate prescriptions may have resulted in 70 hip fractures, 60 other fractures and 14 deaths that would otherwise have been prevented over the 9-month period of the study.
Conclusion: Although it is important for patients to be informed of the risks of medication, media coverage that does not present a balanced view has the potential to do more harm than good.
Comment in
-
Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality.Med J Aust. 2011 Jan 3;194(1):51-2; author reply 52. doi: 10.5694/j.1326-5377.2011.tb04153.x. Med J Aust. 2011. PMID: 21449875 No abstract available.
Similar articles
-
Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality.Med J Aust. 2011 Jan 3;194(1):51-2; author reply 52. doi: 10.5694/j.1326-5377.2011.tb04153.x. Med J Aust. 2011. PMID: 21449875 No abstract available.
-
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.Clin Interv Aging. 2010 Nov 19;5:355-62. doi: 10.2147/CIA.S13909. Clin Interv Aging. 2010. PMID: 21228901 Free PMC article.
-
Benefits and risks of bisphosphonate therapy for osteoporosis.J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82. doi: 10.1210/jc.2012-1027. Epub 2012 Apr 20. J Clin Endocrinol Metab. 2012. PMID: 22523337 Review.
-
Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.Postgrad Med. 2011 Mar;123(2):131-44. doi: 10.3810/pgm.2011.03.2271. Postgrad Med. 2011. PMID: 21474901 Review.
-
Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?Drug Discov Today. 2014 Mar;19(3):312-9. doi: 10.1016/j.drudis.2013.08.010. Epub 2013 Aug 22. Drug Discov Today. 2014. PMID: 23974069 Review.
Cited by
-
Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study.Clin Oral Investig. 2019 Nov;23(11):3967-3975. doi: 10.1007/s00784-019-02828-w. Epub 2019 Feb 12. Clin Oral Investig. 2019. PMID: 30747305
-
Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views.PLoS One. 2016 Jun 29;11(6):e0158365. doi: 10.1371/journal.pone.0158365. eCollection 2016. PLoS One. 2016. PMID: 27355576 Free PMC article.
-
Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.Rheumatol Int. 2013 Sep;33(9):2189-98. doi: 10.1007/s00296-013-2771-7. Epub 2013 May 8. Rheumatol Int. 2013. PMID: 23652790 Review.
-
Adverse effects of media reports on the treatment of osteoporosis.J Endocrinol Invest. 2018 Dec;41(12):1359-1364. doi: 10.1007/s40618-018-0898-9. Epub 2018 May 14. J Endocrinol Invest. 2018. PMID: 29761280 Review.
-
Addressing the spread of health-related misinformation on social networks: an opinion article.Front Med (Lausanne). 2023 May 2;10:1167033. doi: 10.3389/fmed.2023.1167033. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37200966 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical